Cleveland Diagnostics
Cleveland Diagnostics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
About Cleveland Diagnostics
Cleveland Diagnostics is a startup founded in 2018 based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Cleveland Diagnostics is a commercial-stage diagnostics company developing affordable, lab-friendly cancer diagnostic tests using proprietary solvent interaction analysis technology to improve test specificity by investigating protein biomarkers at the structural and cellular level.
Explore Cleveland Diagnostics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.